Skip to content

Life Sciences

Our global Life Sciences practice comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, veterinary, medtech, diagnostics and healthcare sectors.

The practice operates on a cross-border basis and covers the full spectrum of legal support. We advise on mergers and acquisitions, commercial transactions (including licensing and collaborations), IP (both contentious and non-contentious), capital markets and finance, regulatory and dispute resolution. Our international network ensures that we have a ready resource of expertise in a number of jurisdictions, including those in emerging markets, and that we are well positioned to advise on cross-border work.

We have won a reputation for providing far-sighted advice to some of the world’s leading life science companies – including GlaxoSmithKline, Pfizer, UCB, Merck, Bayer and Novartis.

News & Insights

drugs vitamins

News: 03 DECEMBER 2021

Allen & Overy berät mit Life-Sciences-Team Vision Healthcare beim Erwerb von Vitamaze

Allen & Overy hat Vision Healthcare, ein auf Consumer Healthcare spezialisiertes Unternehmen mit einem umfangreichen Portfolio an Self-Care-Marken und rezeptfreien Produkten in mehreren europäischen…

Lesen Sie mehr
abstract cell close up

News: 11 NOVEMBER 2021

Allen & Overy berät Krebsimmuntherapie-Spezialisten iOmx Therapeutics im Rahmen einer Serie-B-Finanzierungsrunde über 65 Millionen Euro

Allen & Overy hat die iOmx Therapeutics AG (iOmx), ein biopharmazeutisches Unternehmen, das Krebsimmuntherapien auf Basis von Immuncheckpoint-Targets der nächsten Generation entwickelt, bei einer…

Lesen Sie mehr
three new counsels in Germany

News: 01 NOVEMBER 2021

Allen & Overy ernennt drei neue Counsel in Deutschland

Allen & Overy hat mit Wirkung zum 1. November 2021 drei neue Counsel berufen.

Lesen Sie mehr

Publications: 16 APRIL 2021

SARS-CoV-2 Arbeitsschutzverordnung: Verpflichtendes Testangebot

Nach wochenlangem zähem Ringen hat das Bundeskabinett beschlossen, Unternehmen deutschlandweit zu verpflichten, ihren Mitarbeitern Coronatests anzubieten. Die Angebotspflicht wird in die SARS-CoV-2…

Lesen Sie mehr

Das sagen andere über uns

Related links

Life Sciences Hub

We report on EU and national regulatory, compliance, intellectual property and transactional developments in the sector.

Read more

CRISPR microsite

The characterisation and optimisation of the CRISPR (also known as CRISPR-Cas) system for gene editing and other applications, is undoubtedly one of the most powerful and ground breaking advances in the history of biotechnology.

Go to microsite

Growth Capital microsite

Allen & Overy is an engaged and active player in the growth company ecosystem.

Go to microsite

Cannabis microsite

According to UN estimates, the global cannabis market is currently worth approximately USD150 billion annually. 

Go to microsite

Download our sector brochure

An insight in to our Life Science and Healthcare sector 2022

Our global Life Sciences and Healthcare sector comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, animal health, consumer health, med tech, and diagnostics sectors.

Related content

Global trends in merger control enforcement

Record levels in the first half of 2018 and considerable contraction in the second.